Eagle Pharmaceuticals, Inc. Operating Lease Liability
Eagle Pharmaceuticals, Inc. had Operating Lease Liability of $2.26 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2023-08-09
- 2023-06-30: Operating Lease, Liability $2.26M.
- 2023-03-31: Operating Lease, Liability $2.64M.
- 2022-12-31: Operating Lease, Liability $3.04M.
- 2022-09-30: Operating Lease, Liability $3.38M.
| Period end | Operating Lease, Liability |
|---|---|
| 2023-06-30 | $2.26M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $2.64M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.04M 10-K · filed 2023-03-23 |
| 2022-09-30 | $3.38M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.73M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.90M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $4.21M 10-K · filed 2022-03-08 |
| 2021-09-30 | $4.25M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.53M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.81M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.08M 10-K · filed 2021-03-05 |
| 2020-09-30 | $3.96M 10-Q · filed 2020-11-02 |
| 2019-12-31 | $4.10M 10-Q · filed 2020-11-02 |